MSc Model-based Drug Development - Pharmacokinetic and Pharmacodynamic Modelling at University of Manchester

Our MSc focuses on the modelling and simulation skills in pharmacokinetics and pharmacodynamics that are transforming the drug industry. Qualify as a mathematical modeller with key skills in computational approaches in pharmacokinetics and pharmacodynamics. Benefit from workshop sessions by applying the skills you develop to real-world data.

Faculty: Faculty of Biology, Medicine and Health  |  Duration: 12 months FT, 29 months PT  |  Study mode: full-time / part-time (distance learning)  |  Intake: 2027 entry  |  Location: Manchester, England, United Kingdom

What you will study

Year 1 (full-time) Term 1 (September to January) Introduction to clinical trials (15 credits). Gain an understanding of the drug development process and explore scientific, statistical and regulatory considerations in the design and interpretation of clinical trials. Compulsory units include Statistics for Health Data Science, PBPK and IVIVE 2 (PHAR68832), Supervised Research Project on M&S - Dissertation, Basic Pharmacokinetics and Pharmacodynamics, PBPK and In Vitro In Vivo Extrapolation (IVIVE) (1) Fundamental Concepts, Data Analysis in Pharmacokinetics and Pharmacodynamics.

Career pathways

Pharmaceutical companies and government regulatory agencies are recognising the value of pharmacokinetic (PK) and pharmacodynamic (PD) modelling and simulation in making the best use of laboratory and clinical data, guiding and expediting drug development, and saving time and costs. A range of well-paid jobs exist in this area across the globe.

Official programme page